Browse > Article
http://dx.doi.org/10.15616/BSL.2019.25.2.196

Upregulation of Nitric Oxide Synthase Activity by All-trans Retinoic Acid and 13-cis Retinoic Acid in Human Malignant Keratinocytes  

Moon, Ki-Young (BioMedicinal Chemistry Laboratory, Department of Clinical Pathology, Gwangju Health University)
Abstract
Effect of retinoids, i.e., all-trans retinoic acid and 13-cis retinoic acid, on the activity of nitric oxide synthase (NOS) was evaluated in human malignant keratinocytes to examine the possible correlation of retinoids with NOS activities. All-trans retinoic acid and 13-cis retinoic acid did not alter the nitric oxide (NO) production. However, in the presence of lipopolysaccharide (LPS, $1{\mu}g/mL$), they significantly increased NO release in a dose-dependent manner until 48 h at concentrations of $50{\sim}100{\mu}M$. The degree of upregulation of NO by all-trans retinoic acid and 13-cis retinoic acid increased up to 35% and 37%, respectively, compared to that by the control, which demonstrated the upregulation of LPS-inducible nitric oxide synthase (iNOS)-dependent generation of NO as well as showing a crucial link between retinoids-induced activity and NOS. Findings of this study now suggest that the upregulation of LPS-iNOS activity may be associated with modulation of retinoids-induced control of cellular developmental processes, which may produce new therapeutics of retinoids in the complexity of how NO affects human keratinocytes.
Keywords
All-trans retinoic acid; 13-cis retinoic acid; Inducible nitric oxide synthase; Nitric oxide; Human malignant keratinocytes;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, Roberts DD, Wink DA. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide. 2008. 19: 73-76.   DOI
2 Rudkin GH, Carlsen BT, Chung CY, Huang W, Ishida K, Anvar B, Yamaguchi DT, Miller TA. Retinoids inhibit squamous cell carcinoma growth and intercellular communication. Journal of Surgical Research. 2002. 103: 183-189.   DOI
3 Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, Sato K, Kudo M, Takeuchi K, Ito S. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation. 2005. 112: 727-736.   DOI
4 Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer. 2001. 1: 181-193.   DOI
5 Aranda E, Lopez-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Nitric oxide and cancer: the emerging role of S nitrosylation. Current Molecular Medicine. 2012. 11: 50-67.
6 Beckenbach L, Baron JM, Merk HF, Loffler H, Amann PM. Retinoid treatment of skin diseases. European Journal of Dermatology. 2015. 5: 384-391.
7 Carratu MR, Marasco C, Mangialardi G, Vacca A. Retinoids: novel immunomodulators and tumour-suppressive agents? British Journal of Pharmacology. 2012. 167: 483-492.   DOI
8 Becherel PA, Chosidow O, Le Goff L, Frances C, Debre P, Mossalayi MD, Arock M. Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria. Molecular Medicine. 1997. 3: 686-694.   DOI
9 Becherel PA, Le Goff L, Ktorza S, Ouaaz F, Mencia-Huerta JM, Dugas B, Debre P, Mossalayi MD, Arock M. Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. European Journal of Immunology. 1995. 25: 2992-2995.   DOI
10 Brune B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death and Differentiation. 1999. 6: 969-975.   DOI
11 Chen YK, Hsue SS, Lin LM. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies. Head Neck. 2002. 24: 925-932.   DOI
12 Cinel L, Polat A, Aydin O, Dusmez D, Egilmez R. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium. Pathology International. 2002. 52: 384-389.   DOI
13 Darwiche N, Bazzi H, El-Touni L, Abou-Lteif G, Doueiri R, Hatoum A, Maalouf S, Gali-Muhtasib H. Regulation of ultraviolet B radiation-mediated activation of AP1 signaling by retinoids in primary keratinocytes. Radiation Research. 2005. 163: 296-306.   DOI
14 Ertesvag A, Naderi S, Blomhoff HK. Regulation of B cell proliferation and differentiation by retinoic acid. Seminars in Immunology. 2009. 21: 36-41.   DOI
15 Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene. 2003. 22: 7305-7315.   DOI
16 Kambhampati S, Li Y, Verma A, Sassano A, Majchrxak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, Uddin S, Minucci S, Tallman MS, Fish EN, Platanias LC. Activation of protein kinase C delta by all-trans-retinoic acid. Journal of Biological Chemistry. 2003. 278: 32544-32551.   DOI
17 Harada K, Supriatno, Kawaguchi S, Tomitaro O, Yoshida H, Sato M. Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo. 2004. 18: 449-455.
18 Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. Journal of Biological Chemistry. 1992. 267: 21277-21280.   DOI
19 Hickok JR, Thomas DD. Nitric oxide and cancer therapy: the emperor has NO clothes. Current Pharmaceutical Design. 2010. 16: 381-391.   DOI
20 Jun CD, Pae HO, Yoo JC, Kwak HJ, Park RK, Chung HT. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells. Cellular Immunology. 1998. 183: 13-21.   DOI
21 Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Seminars in Cancer Biology. 2005. 11: 277-289.   DOI
22 Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treatment Reports. 1987. 71: 391-405.
23 Lippman SM, Meyskens FL Jr. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Annals of Internal Medicine. 1987. 107: 499-502.   DOI
24 Lotan R. Retinoids in cancer chemoprevention. FASEB Journal. 1996. 10: 1031-1039.   DOI
25 Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H. Retinoids in cancer chemoprevention. Current Cancer Drug Targets. 2004. 4: 285-298.   DOI
26 Messmer UK, Lapetina EG, Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Molecular Pharmacology. 1995. 47: 757-765.
27 Moon KY. The chemopreventive effect of retinoids on cellular $NF-{\kappa}B$ activity induced by NMU and NEU in human malignant keratinocytes. Cancer Research and Treatment. 2007. 39: 82-87.   DOI
28 Moon KY. Acrolein, an $I-{\kappa}B{\alpha}-independent$ downregulation of $NF-{\kappa}B$ activity, causes the decrease in nitric oxide production in human malignant keratinocytes. Archives of Toxicology. 2011. 85: 499-504.   DOI
29 Moon KY. N-nitroso-N-methylurea and N-nitroso-N-ethylurea decrease in nitric oxide production in human malignant keratinocytes. Biomedical Science Letters. 2018. 24: 50-54.   DOI
30 Niles RM. The use of retinoids in the prevention and treatment of skin cancer. Expert Opinion Pharmacotherapy. 2002. 3: 299-303.   DOI
31 Ozel E, Pestereli HE, Simsek T, Erdogan G, Karaveli FS. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters? International Journal of Gynecological Cancer. 2006. 16: 549-555.
32 Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Laboratory Investigation. 1999. 79: 1215-1225.